Pulmonx Corp Contracts & Agreements
57 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (1)
- Human Resources (17)
- Real Estate (7)
- Uncategorized (12)
- Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 27, 2024)
- Offer Letter, dated February 19, 2024 by and between Steven S. Williamson and Pulmonx Corporation (Filed With SEC on February 21, 2024)
- Letter Agreement, dated February 20, 2024 by and between Glendon E. French and Pulmonx Corporation (Filed With SEC on February 21, 2024)
- Consulting Agreement, dated November 1, 2023, by and between Pulmonx Corporation and Derrick Sung (Filed With SEC on November 3, 2023)
- Second Amendment to Sublease, by and between Pulmonx Corporation and Genomic Health, Inc., dated April 18, 2023 (Filed With SEC on August 4, 2023)
- Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 4, 2023)
- Third Amendment to Amended and Restated Loan and Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated October 31, 2022 (Filed With SEC on March 1, 2023)
- Second Amendment to Amended and Restated Loan and Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated October 21, 2021 (Filed With SEC on November 9, 2021)
- First Amendment to Amended and Restated Loan and Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated June 17, 2021 (Filed With SEC on August 10, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 12, 2021)
- Third Amendment to Loan and Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated March 29, 2021 (Filed With SEC on May 12, 2021)
- Second Amendment to Loan and Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated December 28, 2020 (Filed With SEC on May 12, 2021)
- Description of common stock of Pulmonx Corporation (Filed With SEC on March 15, 2021)
- Offer Letter Agreement, by and between Pulmonx Corporation and David Lehman, dated September 15, 2020 (Filed With SEC on March 15, 2021)
- Pulmonx Corporation (Filed With SEC on September 28, 2020)
- Pulmonx Corporation Severance and Change in Control Plan and related participation agreement (Filed With SEC on September 28, 2020)
- First Amendment to (Filed With SEC on September 24, 2020)
- Form of Indemnification Agreement by and between Pulmonx Corporation and each of its directors and executive officers (Filed With SEC on September 24, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 24, 2020)
- Form of Restricted Stock Unit Award Agreement under 2020 Equity Incentive Plan (Filed With SEC on September 24, 2020)
- Forms of Option Agreement (Filed With SEC on September 24, 2020)
- 2020 Equity Incentive Plan (Filed With SEC on September 24, 2020)
- 2020 Stock Plan (Filed With SEC on September 24, 2020)
- Form of common stock certificate of Pulmonx Corporation (Filed With SEC on September 24, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 24, 2020)
- Appointment Letter, by and between PulmonX International Srl and Oern R. Stuge, dated December 18, 2013 (Filed With SEC on September 4, 2020)
- Second Amendment to Office Lease, by and between Pulmonx Corporation and HCP LS Redwood City, LLC, dated November 7, 2019 (Filed With SEC on September 4, 2020)
- First Amendment to Office Lease, by and between Pulmonx Corporation and HCP LS Redwood City, LLC, dated October 3, 2014 (Filed With SEC on September 4, 2020)
- Office Lease, by and between Pulmonx Corporation and HCP LS Redwood City, LLC, dated September 4, 2009 (Filed With SEC on September 4, 2020)
- Third Amendment to Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated April 27, 2015 (Filed With SEC on September 4, 2020)
- Amended and Restated Investors Rights Agreement by and among Pulmonx Corporation and certain of its stockholders, dated April 16, 2019 (Filed With SEC on September 4, 2020)
- 2010 Stock Plan, as amended to date (Filed With SEC on September 4, 2020)
- Forms of Notice of Stock Option Grant, Option Agreement, and Exercise Notice under 2010 Stock Plan (Filed With SEC on September 4, 2020)
- 2020 Stock Plan (Filed With SEC on September 4, 2020)
- Forms of Notice of Stock Option Grant, Option Agreement, and Exercise Notice under 2020 Stock Plan (Filed With SEC on September 4, 2020)
- Executive Employment Agreement, by and between Pulmonx Corporation and Glendon E. French, dated December 10, 2014 (Filed With SEC on September 4, 2020)
- Offer Letter Agreement, by and between Pulmonx Corporation and Geoffrey Beran Rose, dated December 11, 2014 (Filed With SEC on September 4, 2020)
- Offer Letter Agreement, by and between Pulmonx Corporation and Derrick Sung, Ph.D., dated March 12, 2019 (Filed With SEC on September 4, 2020)
- Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated October 1, 2013 (Filed With SEC on September 4, 2020)
- Amendment to Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated March 1, 2014 (Filed With SEC on September 4, 2020)
- Second Amendment to Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated July 14, 2014 (Filed With SEC on September 4, 2020)
- 2010 Stock Plan, as amended to date (Filed With SEC on February 28, 2020)
- Amended and Restated Investors Rights Agreement by and among Pulmonx Corporation and certain of its stockholders, dated April 16, 2019 (Filed With SEC on February 28, 2020)
- Forms of Notice of Stock Option Grant, Option Agreement, and Exercise Notice under 2010 Stock Plan (Filed With SEC on February 28, 2020)
- Executive Employment Agreement, by and between Pulmonx Corporation and Glendon E. French, dated December 10, 2014 (Filed With SEC on February 28, 2020)
- Offer Letter Agreement, by and between Pulmonx Corporation and Geoffrey Beran Rose, dated December 11, 2014 (Filed With SEC on February 28, 2020)
- Offer Letter Agreement, by and between Pulmonx Corporation and Derrick Sung, Ph.D., dated March 12, 2019 (Filed With SEC on February 28, 2020)
- Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated October 1, 2013 (Filed With SEC on February 28, 2020)
- Amendment to Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated March 1, 2014 (Filed With SEC on February 28, 2020)
- Second Amendment to Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated July 14, 2014 (Filed With SEC on February 28, 2020)
- Third Amendment to Consulting Agreement, by and between PulmonX International Srl and Orsco Life Sciences AG, dated April 27, 2015 (Filed With SEC on February 28, 2020)
- Appointment Letter, by and between PulmonX International Srl and Oern R. Stuge, dated December 18, 2013 (Filed With SEC on February 28, 2020)
- First Amendment to Office Lease, by and between Pulmonx Corporation and HCP LS Redwood City, LLC, dated October 3, 2014 (Filed With SEC on February 28, 2020)
- Second Amendment to Office Lease, by and between Pulmonx Corporation and HCP LS Redwood City, LLC, dated November 7, 2019 (Filed With SEC on February 28, 2020)
- Intellectual Property Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated February 20, 2020 (Filed With SEC on February 28, 2020)
- Office Lease, by and between Pulmonx Corporation and HCP LS Redwood City, LLC, dated September 4, 2009 (Filed With SEC on February 28, 2020)
- Loan and Security Agreement, by and between Pulmonx Corporation and Canadian Imperial Bank of Commerce, dated February 20, 2020 (Filed With SEC on February 28, 2020)